Terms ending in 2029
Every in-force patent on Dermtech, LLC's record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,057,109 | Diagnosis of Melanoma and Solar Lentigo by Nucleic Acid Analysis In force · Medium confidence | Dermtech, LLC | In force | Medium confidence | |
| US 11,332,795 | Diagnosis of Melanoma and Solar Lentigo by Nucleic Acid Analysis In force · Medium confidence | Dermtech, LLC | In force | Medium confidence | |
| US 11,753,687 | Diagnosis of Melanoma and Solar Lentigo by Nucleic Acid Analysis In force · Medium confidence | Dermtech, LLC | In force | Medium confidence |
3 of 3 patents shown. Soonest term end first, then patent number.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.